Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14–Mutant NSCLC
2020 · Clinical Cancer Research · 210 citations
https://doi.org/10.1158/1078-0432.ccr-19-3608
Y
Ying‐Chun Lo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
84
Papers
685
Citations
12
h-index
17
i10-index
Ying‐Chun Lo is an academic researcher from Mayo Clinic in Arizona. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Cancer Mechanisms and Therapy. The author has an h-index of 12, co-authored 72 publications.
ORCID: 0000-0002-8893-0645Papers by this author
worksDopamine D2 receptor agonists abrogate neuroendocrine tumour angiogenesis to inhibit chemotherapy-refractory small cell lung cancer progression
2025 · Cell Death and Disease · 8 citations
https://doi.org/10.1038/s41419-025-07693-y
Prognostic Immunohistochemistry for Ki-67 and OTP on Small Biopsies of Pulmonary Carcinoid Tumors
2024 · The American Journal of Surgical Pathology · 5 citations
https://doi.org/10.1097/pas.0000000000002227
Superior Vena Cava Syndrome associated with recurrent uterine adenosarcoma
2020 · Gynecologic Oncology Reports · 4 citations
https://doi.org/10.1016/j.gore.2020.100613
Extraaxial Poorly Differentiated Chordoma: Clinicopathologic and Molecular Genetic Characterization
2024 · Modern Pathology · 2 citations
https://doi.org/10.1016/j.modpat.2024.100664
Raphal Cord Rupture
2023 · JACC Case Reports · 1 citations
https://doi.org/10.1016/j.jaccas.2023.101791
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat